Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

NCT02721966 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

503

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Psoratic Arthritis

Interventions

BIOLOGICAL: Secukinumab
DRUG: Secukinumab and Placebo

Sponsor

Novartis Pharmaceuticals